A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome.
A 58-year-old female receiving gemcitabine and cisplatin chemotherapy for stage IV gallbladder cancer developed the clinicoradiologic syndrome, posterior reversible encephalopathy syndrome (PRES). Just before the 4th gemcitabine chemotherapy cycle, she was admitted to the hospital with complaints of headache, dizziness, and generalized tonic-clonic seizures. A MRI was performed on the day when the seizure developed, and the findings showed patchy cortical and subcortical T2 hyperintensity without enhancement that involved both occipital and parietal lobes. Phenytoin loading and maintenance was started for prevention of recurrent seizures, which was successful. The follow-up brain MRI obtained 10 days after the seizure attack showed completely resolved radiologic findings. After the MRI findings revealed complete resolution, phenytoin maintenance was stopped. Even with discontinuation of phenytoin, she had no seizures or other clinical manifestations.
Kwon
Eun Jin
EJ
Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
Kim
Se Won
SW
Kim
Kwang Ki
KK
Seo
Hyung Suk
HS
Kim
Do Yeun
DY
AJNR Am J Neuroradiol. 1998 Mar;19(3):415-7
9541291
Magn Reson Imaging. 2001 Jan;19(1):129-32
11295355
Oncologist. 2007 Nov;12(11):1332-5
18055853
Neuroradiology. 2005 Aug;47(8):586-90
15997391
Acta Oncol. 2004;43(6):590-1
15370618
J Korean Med Sci. 1999 Feb;14(1):89-92
10102531
Lancet. 1992 Aug 22;340(8817):496
1354830
J Korean Med Sci. 2001 Jun;16(3):328-34
11410695
Radiographics. 1998 Mar-Apr;18(2):353-67
9536483
J Clin Oncol. 2006 Oct 1;24(28):e48
17008686
N Engl J Med. 1996 Feb 22;334(8):494-500
8559202
J Clin Oncol. 2007 Jun 10;25(17):2484-6
17557962
J Clin Oncol. 1991 Apr;9(4):679-93
1648599